<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01850498</url>
  </required_header>
  <id_info>
    <org_study_id>1663</org_study_id>
    <nct_id>NCT01850498</nct_id>
  </id_info>
  <brief_title>Epilepsy Motion Sensing</brief_title>
  <official_title>Motion Sensing Study in Epilepsy Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedtronicNeuro</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedtronicNeuro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate patient motion during seizures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To identify and evaluate seizure characteristics derived from an accelerometer that can be used in development of a seizure detection algorithm (compared to EEG readings).</measure>
    <time_frame>While patients are being evaluated in an epilepsy monitoring unit.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the accuracy of an accelerometer in identifying seizures (compared to EEG readings).</measure>
    <time_frame>While patients are being evaluated in an epilepsy monitoring unit.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate whether certain seizure types are more capable of being identified by the accelerometer (compared to EEG readings).</measure>
    <time_frame>While patients are being evaluated in an epilepsy monitoring unit.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate heart rate and rhythm changes associated with seizure onset (compared to ECG readings).</measure>
    <time_frame>While patients are being evaluated in an epilepsy monitoring unit.</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Partial seizures</arm_group_label>
    <description>Partial seizures with secondary generalization which results in visible clonic or tonic-clonic motor behavior</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Generalized seizures</arm_group_label>
    <description>Primarily generalized seizures (in patients with either primary [idiopathic] or secondary [symptomatic] generalized epilepsy), which may involve the following depending on the motor manifestation observed: myoclonic seizures, clonic seizures, tonic-clonic seizures, or atonic seizures.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with epilepsy referred to epilepsy monitoring unit.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Diagnosed with epilepsy and expected to have at least one motor seizure in the EMU&#xD;
&#xD;
          -  Determined by the Investigator to be an acceptable candidate for epilepsy evaluation&#xD;
             with intracranial or scalp electrode monitoring&#xD;
&#xD;
          -  Willing and able to wear 3 ActiGraph GT3X+ devices for the duration of their&#xD;
             participation in the study and comply with the study protocol&#xD;
&#xD;
          -  Have one of the following seizure types: (a) partial seizures with secondary&#xD;
             generalization, which results in visible clonic or tonic-clonic motor behavior; (b)&#xD;
             primarily generalized seizures (in patients with either primary [idiopathic] or&#xD;
             secondary [symptomatic] generalized epilepsy), which may involve the following&#xD;
             depending on the motor manifestation observed: myoclonic seizures, clonic seizures,&#xD;
             tonic-clonic seizures, or atonic seizures.&#xD;
&#xD;
          -  Be able to consent to participate by signing the Informed Consent document after a&#xD;
             full explanation of the nature and purpose of this study&#xD;
&#xD;
          -  Male or non-pregnant female&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently enrolled in another investigational device, drug, or surgery study.&#xD;
             Concurrent physiologic study participation is acceptable&#xD;
&#xD;
          -  Have an implanted device that may interfere with GT3X+ recordings, ECoG/EEG&#xD;
             recordings, ECG recordings, or video recordings&#xD;
&#xD;
          -  Have a movement disorder that may affect GT3X+ recordings&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <study_first_submitted>November 1, 2012</study_first_submitted>
  <study_first_submitted_qc>May 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2013</study_first_posted>
  <last_update_submitted>May 6, 2013</last_update_submitted>
  <last_update_submitted_qc>May 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>Seizure</keyword>
  <keyword>Motor</keyword>
  <keyword>Motion</keyword>
  <keyword>Accelerometer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

